- ￥1125 - 1875
- HuaBio/华安生物
- M1511-3
- 2025年07月15日
- WB,ICC,IHC-P,FC
- Mouse
- Human, Mouse, Rat
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthetic peptide within C-terminal human HDAC3.
- 亚型：
IgG2b
- 形态：
Liquid
- 克隆性：
Mouse monoclonal Antibody
- 标记物：
Non-conjugated
- 适应物种：
Human, Mouse, Rat
- 库存：
现货
- 供应商：
华安生物
- 宿主：
Mouse
- 应用范围：
WB,ICC,IHC-P,FC
- 浓度：
2 mg/mL.
- 规格：
50ul/100ul
| 规格： | 50ul | 产品价格： | ￥1125.0 |
|---|---|---|---|
| 规格： | 100ul | 产品价格： | ￥1875.0 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Histone Deacetylase Activity Assay
Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from the ɛ-amino groups of conserved lysine residues in the amino terminal tail of histones. In humans, there are 18 potential deacetylase enzymes
Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors
Cell cycle checkpoints respond to a wide range of stresses to prevent compromise to the integrity of the cell. The best studied checkpoints are those induced by genotoxic agents that cause DNA damage. Histone deacetylase inhibitors
Evaluation of Histone Deacetylase Inhibitors as Therapeutics for Neurodegenerative Diseases
Various neurodegenerative diseases are associated with aberrant gene expression. We recently identified a novel class of pimelic o -aminobenzamide histone deacetylase (HDAC) inhibitors that show promise as therapeutics
技术资料暂无技术资料 索取技术资料
